The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2R)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-N-[(1S)-1-benzyl-2-[[(1R)-2-carbamoyl-1-(2-furyl)allyl]amino]-2-oxo-ethyl]-5-guanidino-pentanamide ID: ALA4645094
PubChem CID: 156017757
Max Phase: Preclinical
Molecular Formula: C32H40N8O6
Molecular Weight: 632.72
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: C=C(C(N)=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccc(O)cc1)c1ccco1
Standard InChI: InChI=1S/C32H40N8O6/c1-19(28(34)42)27(26-10-6-16-46-26)40-31(45)25(18-20-7-3-2-4-8-20)39-30(44)24(9-5-15-37-32(35)36)38-29(43)23(33)17-21-11-13-22(41)14-12-21/h2-4,6-8,10-14,16,23-25,27,41H,1,5,9,15,17-18,33H2,(H2,34,42)(H,38,43)(H,39,44)(H,40,45)(H4,35,36,37)/t23-,24+,25-,27+/m0/s1
Standard InChI Key: GASMYTNMNVFTEF-ZJMAKVHZSA-N
Molfile:
RDKit 2D
46 48 0 0 0 0 0 0 0 0999 V2000
9.6164 -20.3225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3283 -19.9098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0360 -20.3225 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.3283 -19.0884 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.7478 -19.9098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4597 -20.3225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1715 -19.9098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8833 -20.3225 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.1715 -19.0884 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.4597 -21.1438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7478 -19.0884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4125 -18.6029 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.1600 -17.8216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3386 -17.8216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0821 -18.6029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9046 -19.9098 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.6164 -21.1438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9046 -21.5524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9046 -19.0884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1928 -18.6798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6164 -18.6798 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.1928 -17.8585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4809 -19.0884 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7691 -18.6798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0573 -19.0884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7691 -17.8585 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.3454 -18.6798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6377 -19.0884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9257 -18.6780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2143 -19.0859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2139 -19.9081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9307 -20.3207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6392 -19.9063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0573 -19.9098 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5026 -20.3218 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.1964 -21.1354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4850 -21.5433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4825 -22.3650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1973 -22.7770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9057 -22.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9005 -17.4499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9005 -16.6327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6082 -16.2241 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.6082 -15.4069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3159 -14.9983 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9005 -14.9983 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
2 4 2 0
5 3 1 1
5 6 1 0
6 7 1 0
7 8 1 0
7 9 2 0
6 10 2 0
5 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 11 2 0
1 16 1 6
1 17 1 0
17 18 1 0
16 19 1 0
19 20 1 0
19 21 2 0
20 22 1 0
20 23 1 6
23 24 1 0
24 25 1 0
24 26 2 0
25 27 1 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 28 1 0
25 34 1 1
31 35 1 0
18 36 2 0
36 37 1 0
37 38 2 0
38 39 1 0
39 40 2 0
40 18 1 0
22 41 1 0
41 42 1 0
42 43 1 0
43 44 1 0
44 45 1 0
44 46 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 632.72Molecular Weight (Monoisotopic): 632.3071AlogP: 0.23#Rotatable Bonds: 17Polar Surface Area: 251.68Molecular Species: BASEHBA: 8HBD: 9#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 12#RO5 Violations (Lipinski): 3CX Acidic pKa: 9.50CX Basic pKa: 11.54CX LogP: -0.41CX LogD: -2.55Aromatic Rings: 3Heavy Atoms: 46QED Weighted: 0.04Np Likeness Score: 0.12
References 1. Zhao L, Luo K, Wang Z, Wang Y, Zhang X, Yang D, Ma M, Zhou J, Cui J, Wang J, Han CZ, Liu X, Wang R.. (2020) Design, synthesis, and biological activity of new endomorphin analogs with multi-site modifications., 28 (9): [PMID:32199689 ] [10.1016/j.bmc.2020.115438 ]